The next step is now to harness these newly discovered TDP‐43‐dependent cryptic splicing events and validate them in ALS and FTD patient tissue and biofluids (e.g., cerebrospinal fluid [CSF], blood urine) (Figure 2B). Here, TARDBP is linked to amyotrophic lateral sclerosis.